Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same

A technology of amoxicillin sodium clavulanate potassium and amoxicillin sodium, applied in the field of compound antibiotics and preparation process, new injection packaging form, can solve the problems that no one has developed injection preparations, etc.

Active Publication Date: 2010-02-17
XIANGBEI WELMAN PHARMA CO LTD
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to technical difficulties, no one has developed a 7:1 or other ratio injection formulation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same
  • Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same
  • Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0012] Example 1, preparation and storage of eutectic

[0013] First heat the glass-lined reaction pot, drive out the air, fill it with nitrogen with a humidity below 0.2%, and cool it down. Put 90 L of anhydrous methanol / absolute ethanol (volume ratio 1:30) mixed solution into a glass-lined pot, then put 35 kg of amoxicillin sodium and 5 kg of potassium clavulanate powder into the above solution, and put it under the continuous flow of nitrogen. After heating to 25±2°C, stirring, mixing and dissolving, cooling to 5°C to crystallize, removing the solution under aseptic conditions to obtain a sterile 7:1 eutectic of amoxicillin sodium / potassium clavulanate, the crystal particles are complete , containing low active water. Vacuum dry under a sterile nitrogen flow until the moisture content is below 0.5%. And wash the disposable syringes in the GMP injection powder filling line, and dry the syringes under the clean nitrogen flow, fill the filling machine and syringes (Part A) w...

example 2

[0014] Example 2. Quality research on eutectic stability:

[0015] Properties: The properties of the trial sample are off-white powder.

[0016] Identification: The retention time of the high-performance liquid chromatography peak is compared with that of the reference substance, and compared with the standard substance, it is a qualified product.

[0017] Alkalinity: the pH value of the aqueous solution of this product is 9.0, the quality standard of amoxicillin sodium, its alkalinity range is 8.0~10.0 (aqueous solution, 0.1g / ml), the pH value range of the quality standard of clavulanate potassium is 6.0~ 8.0. The alkalinity range of the trial-produced samples is 8.0-10.0, which is a qualified sample.

[0018] The clarity of the solution: the clarity of the trial sample solution does not exceed the No. 2 turbidity standard solution, which is a qualified sample.

[0019] Related substances: The determination method of related substances is defined as the HPLC reference subs...

example 3

[0040] Example three, the pharmaceutical test of co-crystal

[0041] 1. The protective effect of amoxicillin sodium clavulanate potassium (7:1) compound preparation on mice infected with Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus in vivo.

[0042] Drugs (1) Amoxicillin Sodium for Injection (AMPC). (2) Amoxicillin Sodium Clavulanate Potassium for Injection 7:1 ratio (AMPC / CA). (3) The above-mentioned medicines of Sigeer (amoxicillin sodium and clavulanate potassium 5:1) were all stored in the freezer, and diluted with sterile water for injection before use to the required concentration.

[0043] Animal ICR mice, weighing 18-22g, male and female.

[0044] Experimental strains Three enzyme-producing bacteria strains, Escherichia coli (3128), Pseudomonas aeruginosa (3302) and Staphylococcus aureus (3711), all of the above strains were clinical isolates.

[0045] Protective agent highly active dry yeast, commercially available.

[0046] Experimental meth...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The almoxicillin sodium and clavulanate potassium is widely and clinically used due to good curing effect and safety. The formulations of the almoxicillin sodium and clavulanate potassium are mainly oral preparations in different ratios; because of the advantages of quick response and the like, the injection preparation is deeply and clinically welcomed, but only the 5:1 injection preparation is available in the market at present; and because the clavulanate potassium ratio in the preparation is high, the penicillin anaphylaxis and the high-potassium disease are easily caused, and the preparation is relatively high in price. Because the preparation has the defects of higher process requirements, poor preparation stability, easy decoloring and degradation, and necessary storage and transport at a low temperature, the circulation and use of the medicaments are inconvenient. By changing the ratio of the almoxicillin sodium to the clavulanate potassium and improving the preparation process, the safety of the drugs is improved, the cost of the drugs is lowered and the stability of the drug preparations is improved under a condition of ensuring the curing effect; and simultaneously, because of using a special disposable injector, the conventional complex steps of dissolving and mixing are saved.

Description

Technical field: [0001] The invention relates to the field of medicines, in particular to a compound antibiotic, a preparation process and a new injection packaging form. Background technique: [0002] Amoxicillin (or its sodium salt, amoxicillin sodium) is a β-lactam antibiotic with broad antibacterial spectrum, strong bactericidal power in vivo, good absorption (75-90%), and short peak time (1-2 hours) Its characteristics have been widely used clinically since it was launched in the 1960s. However, due to the emergence of more and more pathogenic strains producing β-lactamase, the pathogenic bacteria can easily cause the β-lactam ring in the amoxicillin molecule to be hydrolyzed and lose its activity, resulting in drug resistance. Potassium clavulanate is an oxypenicillane compound isolated from the culture fluid of Streptomyces, containing a β-lactam ring, which has only weak antibacterial activity, but has a strong broad-spectrum β-lactamase inhibitory effect, which can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/14A61K31/43A61K31/424A61P31/04
Inventor 王霆邓桂兴马宏强孙明杰
Owner XIANGBEI WELMAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com